Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Core Laboratories ( (CLB) ) has provided an update.
Core Laboratories, a Houston-based oilfield services specialist in reservoir description and advanced production enhancement technologies, generated most of its first-quarter 2026 revenue from international and offshore projects, underscoring its exposure to global exploration and production cycles. The company’s portfolio includes proprietary diagnostic tools, RF-safe detonators, and density logging systems designed to optimize completions, de-risk field development, and improve long-term hydrocarbon recovery for clients across North America, the Middle East, and other international markets.
On April 29, 2026, Core Laboratories reported first-quarter 2026 revenue of $121.8 million, down 12% sequentially and flat year over year, with GAAP operating income of $1.9 million and a net loss of $0.02 per share, while non-GAAP metrics showed operating income of $6.6 million and EPS of $0.06. Results were hit by extensive operational disruptions from geopolitical conflict in the Middle East, the Russia-Ukraine war, and severe weather in North America and Europe, which delayed projects, constrained sample access and maritime transport, and damped demand for lab services and completion products; nonetheless, the company highlighted growing adoption of its proprietary technologies, such as NITRO workflows, RF-safe detonators, and PackScan diagnostics, and declared a quarterly cash dividend of $0.01 per share for shareholders of record on May 11, 2026, payable June 1, 2026.
Reservoir Description revenue for the quarter was $81.9 million, down 11% sequentially but slightly above a year earlier, as Middle East conflict and bad weather weighed on client operations, though Core continued to win technically demanding work such as Alaskan North Slope reservoir characterization projects using its NITRO workflow and advanced CT-based core analysis. Production Enhancement revenue came in at $39.9 million, down 13% sequentially and 7% year over year, amid seasonally weak U.S. frac activity, freezing temperatures that temporarily shut completion operations and facilities, and delayed product shipments into the Middle East, partly offset by increased uptake of diagnostic services in the Gulf of Mexico and other international markets.
During the quarter, Core advanced its RF-safe product line with the RF-5TF detonator, which achieved a 100% success rate in field trials and has been adopted across parts of the Eastern Hemisphere, while its PackScan density logging technology helped an offshore Trinidad operator avoid a costly well failure by diagnosing a flawed gravel pack before production. Free cash flow for the quarter was modest at $0.5 million, net debt rose by $3.9 million with leverage at 1.20, and the company repurchased 51,781 shares for about $0.9 million, signaling continued capital return even as near-term macro and geopolitical headwinds weighed on performance and operational visibility.
The most recent analyst rating on (CLB) stock is a Sell with a $11.50 price target. To see the full list of analyst forecasts on Core Laboratories stock, see the CLB Stock Forecast page.
Spark’s Take on CLB Stock
According to Spark, TipRanks’ AI Analyst, CLB is a Neutral.
The score is driven mainly by improved multi-year financial health (steady revenue growth, sustained profits, and better leverage), tempered by weaker and less consistent cash flow in 2025 and some margin softening. Technicals are also a headwind with negative momentum versus key moving averages, while valuation looks only moderately supportive given the 26.3 P/E and very low dividend yield. Earnings call takeaways are mixed: operational wins and capital returns are positives, but profit decline and near-term disruptions/higher interest costs limit upside.
To see Spark’s full report on CLB stock, click here.
More about Core Laboratories
Core Laboratories Inc. is an oilfield services company focused on reservoir description and production enhancement technologies for the global energy industry, with roughly 80% of its reservoir description revenue tied to international and offshore projects and a significant presence in the Middle East and other key hydrocarbon regions worldwide.
Average Trading Volume: 391,961
Technical Sentiment Signal: Buy
Current Market Cap: $796.2M
Learn more about CLB stock on TipRanks’ Stock Analysis page.